ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Missouri » Infectious Disease

Top Infectious Disease Prescribers in Missouri

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
WILLIAM SUMMERS MD

Infectious Disease

9,526

$1.81M

309
106 are 65+

20%
patients receiving schedule two controlled substances

Avg: 3%

29%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 43%

$191
Average prescription price

Avg: $306

DONALD MILLER M.D.

Infectious Disease

6,789

$459K

552
462 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 43%

$68
Average prescription price

Avg: $306

JOHN VERSTRAETE D.O.

Infectious Disease

6,551

$2.53M

172
66 are 65+

27%
patients receiving schedule two controlled substances

Avg: 3%

40%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 43%

$385
Average prescription price

Avg: $306

DAVID BAMBERGER M.D.

Infectious Disease

5,773

$1.2M

219
70 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 43%

$208
Average prescription price

Avg: $306

PAUL L'ECUYER

Infectious Disease

4,530

$237K

318
275 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 43%

$52
Average prescription price

Avg: $306

DONALD KING M.D.

Infectious Disease

4,471

$431K

191
166 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 43%

$96
Average prescription price

Avg: $306

MATTHEW GERMAN M.D.

Infectious Disease

4,144

$1.84M

133
54 are 65+

14%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 5%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 43%

$445
Average prescription price

Avg: $306

JAMES STANFORD M.D.

Infectious Disease

3,998

$583K

153
56 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 43%

$146
Average prescription price

Avg: $306

J CAMPBELL M.D.

Infectious Disease

3,146

$706K

280
235 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 43%

$225
Average prescription price

Avg: $306

JOSEPH FRITZ M.D.

Infectious Disease

2,700

$200K

245
226 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 43%

$74
Average prescription price

Avg: $306

STEVEN LAWRENCE MD

Infectious Disease

2,670

$1.19M

98
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 43%

$446
Average prescription price

Avg: $306

MARCIA SOKOL-ANDERSON MD

Infectious Disease

2,595

$1.82M

137
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

77%
prescriptions for brand name drugs

Avg: 43%

$700
Average prescription price

Avg: $306

NIGAR KIRMANI MD

Infectious Disease

2,330

$1.02M

148
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 43%

$439
Average prescription price

Avg: $306

RAY BURMEISTER M.D.

Infectious Disease

1,954

$744K

52
15 are 65+

21%
patients receiving schedule two controlled substances

Avg: 3%

42%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 43%

$381
Average prescription price

Avg: $306

JOSEPH BREWER M.D.

Infectious Disease

1,708

$438K

130
44 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 43%

$256
Average prescription price

Avg: $306

RACHEL PRESTI MD PHD

Infectious Disease

1,557

$707K

106
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 43%

$454
Average prescription price

Avg: $306

ALASTAIR HADDOW MD

Infectious Disease

1,543

$557K

138
83 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 43%

$361
Average prescription price

Avg: $306

PAUL JOST M.D.

Infectious Disease

1,463

$670K

91
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 43%

$458
Average prescription price

Avg: $306

WILLIAM SISTRUNK MD

Infectious Disease

1,371

$856K

123
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 43%

$624
Average prescription price

Avg: $306

PHILLIP ZINSER MD

Infectious Disease

1,330

$378K

113
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 43%

$284
Average prescription price

Avg: $306

ALAN SALKIND M.D.

Infectious Disease

1,284

$418K

80
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 43%

$325
Average prescription price

Avg: $306

NUR ONEN MD

Infectious Disease

1,280

$706K

96
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 43%

$552
Average prescription price

Avg: $306

CURTIS FITZSIMMONS M.D.

Infectious Disease

1,218

$634K

81
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 43%

$521
Average prescription price

Avg: $306

ERIC FULNECKY MD

Infectious Disease

1,204

$490K

145
78 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 43%

$407
Average prescription price

Avg: $306

JESSICA GRUBB MD

Infectious Disease

942

$459K

116
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 43%

$488
Average prescription price

Avg: $306

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank